DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS

/PRNewswire/ -- Dr. Morris C. Laster ("Dr. Laster"), who, together with other proxy participants, beneficially owns 6,006,000 shares of common stock, par value...

Related Keywords

Jerusalem ,Israel General ,Israel ,Mordechai Saar Hacham ,Joshua Levine ,Raphael Rafi Hofstein ,Davids Battleman ,Company For The Annual Meeting ,Scopus Biopharma Inc ,Company Board Of Directors ,First Coast Results Inc ,Nasdaq ,Citrin Cooperman Company ,Scopus Biopharma ,Coast Results ,Annual Meeting ,Citrin Cooperman ,Chen Laster ,Gabriella Laster ,Sara Laster ,Dr Morrisc Laster ,Health Care Amp Hospitals ,Banking Amp Financial Services ,Shareholder Activism ,